> German biotech Wilex has effectively become a CRO after handing off its drug candidates and focusing on contract work to generate revenue. Story
> WuXi PharmaTech's ($WX) toxicology facility in Suzhou, China, has passed Belgian muster. More
> German biotech Wilex has effectively become a CRO after handing off its drug candidates and focusing on contract work to generate revenue. Story
> WuXi PharmaTech's ($WX) toxicology facility in Suzhou, China, has passed Belgian muster. More